March 2025

SILVER SPRING, Md., March 7, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Wednesday, the FDA approved Encelto (revakinagene taroretcel-lwey), an allogeneic encapsulated cell-based gene therapy for the

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: